@MBSDigest

A newsletter for anyone interested in the latest news about the obesity treatment space: research, technology, industry watch

 USA
mbs-digest.com
Joined April 2026
  • Tweets111
  • Following123
  • Followers31
18Media
Dr. Natan Zundel joins the MBS Digest Editorial Board as International Editor-at-Large. Clinical Professor of Surgery at the University at Buffalo, Past President of IFSO and IFSES, Executive Director of FELAC.
1
2
mbs-digest.com/editorial-boa…

Editorial Board

A free newsletter directed towards bariatric surgeons, obesity medicine specialists, industry sponsors, policy makers, investors, and the general public.

mbs-digest.com
Bariatric teams: the Tennessee ASMBS chapter meets October 30 in Nashville to discuss advances in metabolic and bariatric surgery and emerging treatments. Today's society announcement includes registration details. xitter.cf/ASMBS/status/211366177…
ASMBS@ASMBSOct 23
Join the Tennessee Chapter of #ASMBS on October 30, 2026, at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee. Explore advancements in metabolic and bariatric surgery, emerging treatment options, and more. Register here to attend: buff.ly/RjrnAd3
1
16
The latest Staple Line is out: surgery and cancer, late clots after sleeve, and Revita after tirzepatide. Catch the Oct. 21 episode of the MBS Digest audio edition: mbs-digest.com/podcast/s/the…

Vol. 2, No. 15: Surgery and cancer, late clots after sleeve, and Revita after tirzepatide

Vol. 2, No. 15. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 15 ( https://www.mbs-digest.com/p/cancer-risk-after-bariatric-surgery-late-sleeve-thrombosis-a...

mbs-digest.com
1
1
39
New on The Staple Line, the weekly audio edition of MBS Digest. Vol. 2, No. 15, 11 minutes: surgery and cancer, with one signal pointing the other way. Why clots after a sleeve can show up late. A sponsor-reported Revita result. An oral GLP-1 in Europe. Link in reply.
1
10
mbs-digest.com/podcast/s/the…

Vol. 2, No. 15: Surgery and cancer, late clots after sleeve, and Revita after tirzepatide

Vol. 2, No. 15. The weekly audio edition of MBS Digest. Full issue with every source, free: read Issue 15 ( https://www.mbs-digest.com/p/cancer-risk-after-bariatric-surgery-late-sleeve-thrombosis-a...

mbs-digest.com
2
MBS Digest Vol. 2, Issue 15: bariatric surgery and cancer incidence in 784,105 Nordic adults (aIRR 0.81; pancreatic cancer 1.19); 29% of sleeve-associated portomesenteric thromboses diagnosed after week 4; 12-year RYGB mortality 4.34% vs 7.11%. Link in reply.
1
1
1
40
mbs-digest.com/p/cancer-risk…

Cancer Risk After Bariatric Surgery, Late Sleeve Thrombosis, and RYGB Survival

Lower obesity-related cancer incidence with a pancreatic counter-signal, late sleeve-associated thrombosis, and 12-year RYGB mortality--ALL IN THIS FREE ISSUE

mbs-digest.com
7
MBS Digest cambia su nombre completo: ahora es el Metabolic and Bariatric Sciences Digest (Resumen de Ciencias Metabólicas y Bariátricas). La sigla, el boletín semanal y el comité editorial siguen igual. La cirugía sigue siendo central en esta misión.
1
2
El editorial del Editor de Producción: mbs-digest.com/p/un-nombre-q…

Un nombre que refleja la atención que brindamos

Un editorial sobre el cambio de nombre a Metabolic and Bariatric Sciences Digest

mbs-digest.com
1
MBS Digest has a new full name: the Metabolic and Bariatric Sciences Digest. The initials, the weekly briefing and the editorial board stay the same. Surgery remains central; the name now covers the full range of obesity care our readers work in.
1
1
1
26
The Production Editor's editorial on why the name changed: mbs-digest.com/p/a-name-that…

A name that reflects the care we provide

An editorial on renaming the Digest the Metabolic and Bariatric Sciences Digest

mbs-digest.com
1
1
26
Weight recurrence deserves a careful revision discussion, not an automatic trip back to the OR. ASMBS is highlighting its Weekend session, ‘Just One More Hand: Weight Recurrence Revisions.’ Education, not a new outcomes study. xitter.cf/ASMBS/status/211040105…
ASMBS@ASMBSOct 14
Join us for “Just One More Hand: Weight Recurrence Revisions” at #ASMBSWeekend: buff.ly/5XPqLLp #ASMBSWeekend #ASMBS #BariatricSurgery #MetabolicHealth #Health #MedEd #CME #CE #MedicalConference #HealthcareEducation #IntegratedHealth #surgery #SurgEd #BariatricNurse
1
2
44
MBS Digest N.º 14 (edición en español): a los 12 años, el 74,2% de los encuestados volvería a elegir la cirugía; GLP-1 ante la reganancia de peso (14,8% frente a 8,1% del peso recuperado perdido al año); SADI-S simulada en dos etapas (11,5% frente a 6,7%). Enlace en la respuesta.
1
6
mbs-digest.com/p/mbs-digest-…

MBS Digest — Vol. 2, N.o 14 (Edición en Español)

Agonistas del GLP-1 para la reganancia de peso, la satisfacción de los pacientes a los 12 años y el riesgo modelado de complicaciones de la SADI-S en dos etapas.

mbs-digest.com
3
MBS Digest Vol. 2, Issue 14: 74.2% of surveyed patients would choose bariatric surgery again 12 years out; GLP-1 agonists after weight regain (14.8% vs 8.1% of regained weight lost at 12 months); simulated two-stage SADI-S at 11.5% complications vs 6.7%. Link in reply.
1
11
mbs-digest.com/p/are-patient…

Are Patients Satisfied Long Term, GLP-1 for Weight Recurrence, Staged SADI-S, and Trocar AI: All in...

GLP-1 agonists for weight recurrence, patient satisfaction 12 years out, and the modeled complication risk of staged SADI-S.

mbs-digest.com
7
ASMBS is highlighting a 5.5-CME course on business and financial literacy for bariatric surgeons. Practice growth deserves the same deliberate education we give new techniques. xitter.cf/ASMBS/status/210750205…
ASMBS@ASMBSOct 6
Silver Dollars and Sense: Business and Financial Literacy for Bariatric Surgeons offers practical guidance on practice growth. Earn 5.5 CME credits: buff.ly/QJLc94j #ASMBS #BariatricSurgery #MetabolicHealth #Healthcare #ObesityCare #ObesityTreatment #Obesity
9
Better treatments mean little if patients cannot access them. MBS Digest Issue 13 examines a 51-jurisdiction access scorecard, weight recurrence after bypass, and obesity drug efficacy and safety. Disclosure: editor John Scott co-authored the scorecard.
1
1
18
mbs-digest.com/p/state-by-st…

State by State Scorecards, RYGB Weight Recurrence, Hiatal Repair: all in this week's MBS DIGEST

Weight recurrence after RYGB, five-year esophagitis after sleeve, and new drug trials that separate weight-loss efficacy from tolerability and proven cardiovascular benefit.

mbs-digest.com
5
Load more